Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: HCC, . Treffer: 108

2020

Cubero, FJ; Mohamed, MR; Woitok, MM; Zhao, G; Hatting, M; Nevzorova, YA; Chen, C; Haybaeck, J; de Bruin, A; Avila, MA; Boekschoten, MV; Davis, RJ; Trautwein, C Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
Hepatol Commun. 2020; 4(6): 834-851. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Nardo, AD; Grün, NG; Zeyda, M; Dumanic, M; Oberhuber, G; Rivelles, E; Helbich, TH; Markgraf, DF; Roden, M; Claudel, T; Trauner, M; Stulnig, TM Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma.
Liver Int. 2020; 40(7):1620-1633 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2019

Czepukojc, B; Abuhaliema, A; Barghash, A; Tierling, S; Nass, N; Simon, Y; Korbel, C; Cadenas, C; van Hul, N; Sachinidis, A; Hengstler, JG; Helms, V; Laschke, MW; Walter, J; Haybaeck, J; Leclercq, I; Kiemer, AK; Kessler, SM IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
FRONT MED-LAUSANNE. 2019; 6: 179 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Denk, H; Stumptner, C; Abuja, PM; Zatloukal, K Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Expert Opin Ther Targets. 2019; 23(5):393-406
Web of Science PubMed FullText FullText_MUG

 

Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kröhler, T; Kessler, SM; Hosseini, K; List, M; Barghash, A; Patial, S; Laggai, S; Gemperlein, K; Haybaeck, J; Müller, R; Helms, V; Schulz, MH; Hoppstädter, J; Blackshear, PJ; Kiemer, AK The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.
Cancers (Basel). 2019; 11(11): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lackner, C; Quagliata, L; Cross, W; Ribi, S; Heinimann, K; Paradiso, V; Quintavalle, C; Kovacova, M; Baumhoer, D; Piscuoglio, S; Terracciano, L; Kovac, M Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma.
SCI REP-UK. 2019; 9(1): 4611-4611. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lokau, J; Schoeder, V; Haybaeck, J; Garbers, C Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.
Cancers (Basel). 2019; 11(11): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Apostolidis, L; Pfeiffenberger, J; Gotthardt, D; Radeleff, B; Mehrabi, A; Schemmer, P; Jager, D; Schirmacher, P; Stremmel, W; Schulze-Bergkamen, H; Springfeld, C; Weiss, KH Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
GASTROINTEST TUMORS. 2018; 5(1-2): 38-46. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Filali Bouami, S; Gwiasda, J; Beneke, J; Kaltenborn, A; Liersch, S; Suero, EM; Koch, HF; Krauth, C; Klempnauer, J; Schrem, H Prognostic factors for long-term survival after adult liver transplantation.
Langenbecks Arch Surg. 2018; 403(4): 495-508.
Web of Science PubMed FullText FullText_MUG

 

Heits, N; Brosch, M; Herrmann, A; Behrens, R; Röcken, C; Schrem, H; Kaltenborn, A; Klempnauer, J; Kreipe, HH; Reichert, B; Lenschow, C; Wilms, C; Vogel, T; Wolters, H; Wardelmann, E; Seehofer, D; Buch, S; Zeissig, S; Pannach, S; Raschzok, N; Dietel, M; von Schoenfels, W; Hinz, S; Teufel, A; Evert, M; Franke, A; Becker, T; Braun, F; Hampe, J; Schafmayer, C Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma.
Transplantation. 2018; 102(10): e424-e430-e424-e430.
Web of Science PubMed FullText FullText_MUG

 

Kozbial, K; Moser, S; Al-Zoairy, R; Schwarzer, R; Datz, C; Stauber, R; Laferl, H; Strasser, M; Beinhardt, S; Stättermayer, AF; Gschwantler, M; Zoller, H; Maieron, A; Graziadei, I; Trauner, M; Steindl-Munda, P; Hofer, H; Ferenci, P Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Liver Int. 2018; 38(6):1028-1035 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krstic, J; Galhuber, M; Schulz, TJ; Schupp, M; Prokesch, A p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.
Int J Mol Sci. 2018; 19(3): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Li, M; Su, Y; Zhang, F; Chen, K; Xu, X; Xu, L; Zhou, J; Wang, W A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Acta Biomater. 2018; 75: 413-426.
Web of Science PubMed FullText FullText_MUG

 

Piros, L; Máthé, Z [Laparoscopy in liver surgery].
Magy Onkol. 2018; 62(1):37-44 [OPEN ACCESS]
PubMed

 

Qu, Z; Ling, Q; Gwiasda, J; Xu, X; Schrem, H; Beneke, J; Kaltenborn, A; Krauth, C; Mix, H; Klempnauer, J; Emmanouilidis, N Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Langenbecks Arch Surg. 2018; 403(5): 643-654.
Web of Science PubMed FullText FullText_MUG

 

Seitz, HK; Bataller, R; Cortez-Pinto, H; Gao, B; Gual, A; Lackner, C; Mathurin, P; Mueller, S; Szabo, G; Tsukamoto, H Alcoholic liver disease.
Nat Rev Dis Primers. 2018; 4(1):16-16
Web of Science PubMed FullText FullText_MUG

 

Sunderkötter, CH; Zelger, B; Chen, KR; Requena, L; Piette, W; Carlson, JA; Dutz, J; Lamprecht, P; Mahr, A; Aberer, E; Werth, VP; Wetter, DA; Kawana, S; Luqmani, R; Frances, C; Jorizzo, J; Watts, JR; Metze, D; Caproni, M; Alpsoy, E; Callen, JP; Fiorentino, D; Merkel, PA; Falk, RJ; Jennette, JC Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.
Arthritis Rheumatol. 2018; 70(2):171-184 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Douschan, P; Rainer, F; Stauber, R; Haybaeck, J; Denk, H; Lackner, C Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017; 37(4):600-610
Web of Science PubMed FullText FullText_MUG

 

Cătană, CS; Pichler, M; Giannelli, G; Mader, RM; Berindan-Neagoe, I Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.
Oncotarget. 2017; 8(17):29519-29534 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Golob-Schwarzl, N; Krassnig, S; Toeglhofer, AM; Park, YN; Gogg-Kamerer, M; Vierlinger, K; Schröder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
Eur J Cancer. 2017; 83(60):56-70
Web of Science PubMed FullText FullText_MUG

 

Görtz, M; Galli, U; Longerich, T; Zöller, M; Erb, U; Schemmer, P De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.
Oncol Rep. 2017; 38(5):2697-2704 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gwiasda, J; Schulte, A; Kaltenborn, A; Ramackers, W; Kleine, M; Beetz, O; Klempnauer, J; Emmanouilidis, N; Schrem, H Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.
Surg Oncol. 2017; 26(2): 178-187.
Web of Science PubMed FullText FullText_MUG

 

Lin, S; Hoffmann, K; Gao, C; Petrulionis, M; Herr, I; Schemmer, P Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma.
J PINEAL RES. 2017; 62(3):
Web of Science PubMed FullText FullText_MUG

 

Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schneider, AT; Gautheron, J; Feoktistova, M; Roderburg, C; Loosen, SH; Roy, S; Benz, F; Schemmer, P; Büchler, MW; Nachbur, U; Neumann, UP; Tolba, R; Luedde, M; Zucman-Rossi, J; Panayotova-Dimitrova, D; Leverkus, M; Preisinger, C; Tacke, F; Trautwein, C; Longerich, T; Vucur, M; Luedde, T RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer.
Cancer Cell. 2017; 31(1):94-109 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wimmer, T; Steiner, J; Talakic, E; Stauber, R; Quehenberger, F; Portugaller, RH; Schoellnast, H Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
J Comput Assist Tomogr. 2017; 41(5):708-712
Web of Science PubMed FullText FullText_MUG

 

2016

Bettermann, K; Mehta, AK; Hofer, EM; Wohlrab, C; Golob-Schwarzl, N; Svendova, V; Schimek, MG; Stumptner, C; Thüringer, A; Speicher, MR; Lackner, C; Zatloukal, K; Denk, H; Haybaeck, J Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis.
Oncotarget. 2016; 7(45):73309-73322 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Emmanouilidis, N; Peters, R; Ringe, BP; Güner, Z; Ramackers, W; Bektas, H; Lehner, F; Manns, M; Klempnauer, J; Schrem, H Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience.
J Transplant. 2016; 2016(5): 7895956-7895956. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jeric, I; Maurer, G; Cavallo, AL; Raguz, J; Desideri, E; Tarkowski, B; Parrini, M; Fischer, I; Zatloukal, K; Baccarini, M A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis.
Nat Commun. 2016; 7(12):13781-13781 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Trierweiler, C; Hockenjos, B; Zatloukal, K; Thimme, R; Blum, HE; Wagner, EF; Hasselblatt, P The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Cell Death Differ. 2016; 23(4):576-582 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Egger, J; Busse, H; Brandmaier, P; Seider, D; Gawlitza, M; Strocka, S; Voglreiter, P; Dokter, M; Hofmann, M; Kainz, B; Chen, X; Hann, A; Boechat, P; Yu, W; Freisleben, B; Alhonnoro, T; Pollari, M; Moche, M; Schmalstieg, D RFA-cut: Semi-automatic segmentation of radiofrequency ablation zones with and without needles via optimal s-t-cuts.
Conf Proc IEEE Eng Med Biol Soc. 2015; 2015(2):2423-2429
PubMed FullText FullText_MUG

 

Ehedego, H; Boekschoten, MV; Hu, W; Doler, C; Haybaeck, J; Gaβler, N; Müller, M; Liedtke, C; Trautwein, C p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
Cancer Res. 2015; 75(6):1144-1155 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Elgohary, N; Pellegrino, R; Neumann, O; Elzawahry, HM; Saber, MM; Zeeneldin, AA; Geffers, R; Ehemann, V; Schemmer, P; Schirmacher, P; Longerich, T Protumorigenic role of Timeless in hepatocellular carcinoma.
Int J Oncol. 2015; 46(2):597-606 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kessler, SM; Laggai, S; Barghash, A; Schultheiss, CS; Lederer, E; Artl, M; Helms, V; Haybaeck, J; Kiemer, AK IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.
Cell Death Dis. 2015; 6(1):e1894-e1894 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Nashan, B; Schemmer, P; Braun, F; Dworak, M; Wimmer, P; Schlitt, H Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.
Trials. 2015; 16(8):118-118 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pfeiffenberger, J; Mogler, C; Gotthardt, DN; Schulze-Bergkamen, H; Litwin, T; Reuner, U; Hefter, H; Huster, D; Schemmer, P; Członkowska, A; Schirmacher, P; Stremmel, W; Cassiman, D; Weiss, KH Hepatobiliary malignancies in Wilson disease.
Liver Int. 2015; 35(5):1615-1622
Web of Science PubMed FullText FullText_MUG

 

Piros, L; Fehérvári, I; Görög, D; Nemes, B; Szabó, J; Gerlei, Z; Végső, G; Kóbori, L; Máthé, Z Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Transplant Proc. 2015; 47(7):2201-2206
Web of Science PubMed FullText FullText_MUG

 

Reichl, P; Fang, M; Starlinger, P; Staufer, K; Nenutil, R; Muller, P; Greplova, K; Valik, D; Dooley, S; Brostjan, C; Gruenberger, T; Shen, J; Man, K; Trauner, M; Yu, J; Gao, CF; Mikulits, W Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Int J Cancer. 2015; 137(2):385-394 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rutter, K; Stättermayer, AF; Beinhardt, S; Scherzer, TM; Steindl-Munda, P; Trauner, M; Ferenci, P; Hofer, H Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.
Aliment Pharmacol Ther. 2015; 41(6):521-531 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sadeghi, M; Lahdou, I; Oweira, H; Daniel, V; Terness, P; Schmidt, J; Weiss, KH; Longerich, T; Schemmer, P; Opelz, G; Mehrabi, A Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Br J Cancer. 2015; 113(5):756-762 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

2014

Bruns, H; Petrulionis, M; Schultze, D; Al Saeedi, M; Lin, S; Yamanaka, K; Ambrazevičius, M; Strupas, K; Schemmer, P Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells.
Amino Acids. 2014; 46(4):969-976
Web of Science PubMed FullText FullText_MUG

 

Flecken, T; Schmidt, N; Hild, S; Gostick, E; Drognitz, O; Zeiser, R; Schemmer, P; Bruns, H; Eiermann, T; Price, DA; Blum, HE; Neumann-Haefelin, C; Thimme, R Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Hepatology. 2014; 59(4):1415-1426 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Friedrich, K; Wannhoff, A; Kattner, S; Brune, M; Hov, JR; Weiss, KH; Antoni, C; Dollinger, M; Neumann-Haefelin, C; Seufferlein, T; Schemmer, P; Schirmacher, P; Stremmel, W; Gotthardt, DN PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
J Gastroenterol Hepatol. 2014; 29(7):1477-1484
Web of Science PubMed FullText FullText_MUG

 

García-Rodríguez, JL; Barbier-Torres, L; Fernández-Álvarez, S; Gutiérrez-de Juan, V; Monte, MJ; Halilbasic, E; Herranz, D; Álvarez, L; Aspichueta, P; Marín, JJ; Trauner, M; Mato, JM; Serrano, M; Beraza, N; Martínez-Chantar, ML SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
Hepatology. 2014; 59(5):1972-1983 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Herz, C; Hertrampf, A; Zimmermann, S; Stetter, N; Wagner, M; Kleinhans, C; Erlacher, M; Schüler, J; Platz, S; Rohn, S; Mersch-Sundermann, V; Lamy, E The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
J Cell Mol Med. 2014; 18(12):2393-2403 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum